Bayer Helps Flood Victims In Mexico

Main Category: Aid / Disasters
Article Date: 23 Nov 2007 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Prompted by the emergency in the Mexican state of Tabasco after the heavy floods over the past few days, Bayer has decided to help flood victims by donating medicines and insecticides.

"The situation in Mexico is quite dramatic, so we want to help alleviate the distress of the people and in particular reduce the health hazards," said Werner Wenning, Chairman of the Board of Management of Bayer AG. Working closely with the Mexican Ministry of Health, Bayer's Mexican subsidiary is providing the authorities in Tabasco with urgently required medicines and products for the professional combating of insects and other carriers of diseases. In all, the value of the donation will total over US-Dollar 350,000. "As the water level drops, the full extent of the damage is gradually becoming apparent. We now need to help the people in those areas," says Georg Braunleder, Managing Director of the Bayer subsidiary in Mexico.

Heavy rainfall in southern Mexico has caused the worst floods for half a century. Vast swathes of the Mexican state of Tabasco were submerged in water, about a million people were made homeless, and this year's crops were largely destroyed. Moreover, the lack of drinking water and the dead animals floating in the water are continuing to cause an acute risk of diseases.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company's products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and improved earning power. The Group is committed to the principles of sustainable development and acknowledges and accepts its role as a socially and ethically responsible "corporate citizen". Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2006, Bayer employed 106,000 people and had sales of around EUR 29 billion. Capital expenditures amounted to EUR 1.7 billion, the R&D budget to EUR 2.3 billion.

Forward-Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports to the Frankfurt Stock Exchange and in our reports filed with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Bayer
Bayer